Purpose: Magnification is commonly used to reduce the impact of impaired central vision. However, magnification limits the field of view (FoV) which may make it difficult to follow the story. Most people with normal vision look in about the same place at about the same time, the center of interest (COI), when watching "Hollywood" movies. We hypothesized that if the FoV was centered at the COI, then this view would provide more useful information than either the original image center or an unrelated view location (the COI locations from a different video clip) as the FoV reduced.
Methods: The FoV was varied between 100% (original) and 3%. To measure video comprehension as the FoV reduced, subjects described 30-second video clips in response to two open-ended questions. A computational, natural-language approach was used to provide an information acquisition (IA) score.
Results: The IA scores reduced as the FoV decreased. When the FoV was around the COI, subjects were better able to understand the content of the video clips (higher IA scores) as the FoV decreased than the other conditions. Thus, magnification around the COI may serve as a better video enhancement approach than simple magnification of the image center.
Conclusions: These results have implications for future image processing and scene viewing, which may help people with central vision loss view directed dynamic visual content ("Hollywood" movies).
Translational Relevance: Our results are promising for the use of magnification around the COI as a vision rehabilitation aid for people with central vision loss.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422781 | PMC |
http://dx.doi.org/10.1167/tvst.9.8.6 | DOI Listing |
PLoS One
January 2025
Division of Ophthalmology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America.
Purpose: The purpose of this systematic review was to consolidate and summarize available data comparing virtual reality perimetry (VRP) with standard automated perimetry (SAP) in adults with glaucoma. Understanding the utility and diagnostic performance of emerging VRP technology may expand access to visual field testing but requires evidence-based validation.
Methods: A systematic literature search was conducted in 3 databases (PubMed Central, Embase, and Cochrane Central Register of Controlled Trials) from the date of inception to 10/09/2024.
Invest Ophthalmol Vis Sci
January 2025
Laboratorio de Óptica, Universidad de Murcia, Campus de Espinardo, Murcia, Spain.
Purpose: Peripheral optics have been suggested to play a role in myopia progression, with accommodation responses also considered a potential contributor. This study aimed to investigate whether modifications in peripheral optics through different spectacle lenses affect accommodation responses.
Methods: Dynamic accommodation responses were assessed using a double-pass instrument while switching the target from distance (3 m for 3 seconds) to near (0.
Drug Deliv Transl Res
January 2025
Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, Northeastern University, Boston, MA, 02115, USA.
Age-related macular degeneration (AMD) is one of the leading causes of central vision loss in the elderly population. Bevacizumab, a full-length humanized monoclonal anti-VEGF antibody, is commonly used off-label drug to treat AMD. However, the dosing regimen of bevacizumab and other anti-VEGF antibodies requires monthly intravitreal injections followed by regular intravitreal injections at 4-16-week intervals.
View Article and Find Full Text PDFNeurol Int
December 2024
Stroke Unit, Department of Neurology, University of Pécs, 7624 Pécs, Hungary.
Acute retinal ischemia, including central retinal artery occlusion (CRAO), is recognized as a stroke equivalent by the American Heart Association/American Stroke Association (AHA/ASA), necessitating immediate multidisciplinary evaluation and management. However, referral patterns among ophthalmologists remain inconsistent, and evidence-based therapeutic interventions to improve visual outcomes are currently lacking. CRAO is associated with a significantly elevated risk of subsequent acute ischemic stroke (AIS), particularly within the first week following diagnosis, yet the role of intravenous thrombolysis (IVT) in this setting remains controversial.
View Article and Find Full Text PDFFront Neurol
January 2025
Department of Orthopaedics, China-Japan Union Hospital of Jilin University, Changchun, China.
Retinal ganglion cells (RGCs) generally fail to regenerate axons, resulting in irreversible vision loss after optic nerve injury. While many studies have shown that modulating specific genes can enhance RGCs survival and promote optic nerve regeneration, inducing long-distance axon regeneration through single-gene manipulation remains challenging. Nevertheless, combined multi-gene therapies have proven effective in significantly enhancing axonal regeneration.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!